Instalab
logoInstalab

Estrone

Saliva Test
Explore your active estrogen with a simple saliva sample, a noninvasive window into your shifting hormone balance.
4.9 (2,138 reviews)
Tested by Doctor's Data
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Estrone test?

This test is most useful if any of these apply to you.

Going Through or Past Menopause
Your estrogen shifts as your ovaries wind down, and this offers a needle-free look at the active fraction as your body changes.
Curious About Your Hormones
You want an exploratory read on your active estrogen without a blood draw, using a simple saliva sample you collect yourself.
Watching the Weight and Estrogen Link
Body fat is the biggest driver of estrogen after menopause, and this gives an early read on where your levels may sit.
Healthy but Want an Early Baseline
You feel well but want a personal starting point you can track over the years as the science on this marker matures.

About Estrone

If you are moving through menopause, watching your hormone balance, or simply curious about your estrogen, this test offers a way to check one of your key estrogens without a needle. Saliva captures the freely active fraction of the hormone, the part not locked to carrier proteins in your blood.

The honest caveat comes first. Salivary estrone is a research-stage measurement, not a validated clinical test. Its real value is giving you a personal baseline you can watch over time, rather than a single verdict about your health.

What Salivary Estrone Captures

Estrone (E1) is one of three main estrogens your body makes. After menopause it becomes the dominant one, because the ovaries slow down and body fat takes over most estrogen production. In blood, the majority of estrone travels bound to proteins, and only the small free portion drifts into saliva.

That free portion is what a saliva test measures. Early physiology work found salivary estrogens sit at only a small fraction of blood levels, commonly reported in the range of about 1 to 8 percent for estrogens generally, so the number reflects the unbound, biologically available hormone. It also means the test operates at very low concentrations, which makes it technically demanding and sensitive to interference.

Body Fat and Estrogen Exposure

In postmenopausal women, the single biggest driver of estrone is body fat. Among 4,068 postmenopausal women, average blood estrone was roughly 60 percent higher in those with a BMI over 30 compared with under 25 (30.6 versus 19.1 pg/mL). Fat tissue carries an enzyme that converts other hormones into estrogen, so more fat means more estrone.

This matters because higher long-term estrogen exposure is tied to hormone-driven breast cancer. In one prevention trial, a drug that shuts down that fat-tissue enzyme cut invasive breast cancer incidence by 65 percent versus placebo in healthy postmenopausal women. These findings come from blood estrogen measurements, not saliva, so they inform the biology rather than validate the saliva test directly.

The Keratoconus Signal

The clearest direct evidence for salivary estrone comes from keratoconus, a condition in which the cornea thins and bulges into a cone shape. Two studies found lower salivary estrone in patients than in healthy controls. The larger one, with 147 patients and 60 controls, saw the reduction hold across sex, age, and disease severity; a smaller study of 64 patients and 14 controls found reduced estrone alongside elevated DHEA-S.

These are associations, not proof of cause. They do not make salivary estrone a diagnostic test for keratoconus, and no study here reports how accurately estrone alone could separate patients from healthy people.

Making Sense of Two Opposite Directions

These threads can seem to contradict each other: too much estrone links to breast cancer risk, while too little salivary estrone shows up in keratoconus. Estrone is not a simple good number or bad number marker. It reflects a hormonal state, and different states carry different risks in different tissues. What a given level means depends on your context: your age, sex, body composition, and reproductive stage. That is why a value only becomes interpretable alongside the rest of your picture.

Pregnancy and a Related Storage Form

In pregnancy, a related molecule called estrone sulfate rises steadily. Across 106 pregnant women tested weekly, salivary estrone sulfate roughly doubled through the second trimester as a noninvasive window into fetal and placental function. Estrone sulfate is a stored, inactive form rather than estrone itself, so this is a related but different measurement. Researchers who reported it still describe the approach as exploratory and in need of more validation.

Why One Reading Tells You Little

Because salivary estrone sits at such low concentrations, a single reading is easily swayed by measurement noise. Levels also differ by sex, running higher in women, and decline modestly with age. That combination makes the trend far more informative than any one snapshot.

No clinical guideline recommends a schedule for serial salivary estrone monitoring, so any retesting rhythm is a personal choice rather than an evidence-based protocol. If you do choose to track it, a baseline now with a repeat when you are changing your weight or lifestyle can show whether your own value is moving. One caveat: most of the evidence on what moves estrone was measured in blood, so a saliva retest may not mirror a blood change exactly. Watching your own saliva trend against your own baseline is the most reliable use of this data.

What an Unexpected Result Should Prompt

If your salivary estrone lands far from what you expected, the next move is not to act on the saliva number alone. Confirm it with a standard blood estrogen panel that includes estradiol and estrone, and consider adding FSH and LH to place your reproductive stage in context. An endocrinologist or your primary clinician can help read the combination rather than the single figure.

For postmenopausal women concerned about estrogen and breast cancer risk, this marker is a complement to, not a substitute for, standard screening and a body-composition review. Patterns across several tests carry the weight here; an isolated saliva value does not.

When Results Can Be Misleading

  • Low-level assay bias: at the very low concentrations found in saliva, immunoassays for salivary estrogens tend to read falsely high, a pattern documented for salivary estradiol using the same style of test. A number that looks reassuringly normal may be inflated.
  • Blood in the sample: even a trace of blood from brushing your teeth, flossing, or gum irritation can substantially shift a salivary steroid reading, because blood levels are far higher than saliva levels.
  • Sex and age: women run higher than men and levels drift down with age, so a value only makes sense compared against people like you, not a generic reference.
  • Collection technique: timing, contamination from food or drink, and inconsistent sampling can all move the number before the lab ever runs it.

What Moves This Biomarker

Evidence-backed interventions that affect your Estrone level

Decrease
Take an aromatase inhibitor (such as letrozole or exemestane)
Aromatase inhibitors shut down the enzyme that builds estrone from other hormones, and they are the standard treatment for estrogen-driven breast cancer in postmenopausal women. In a trial of postmenopausal breast cancer patients, letrozole drove blood estrone below the level the assay could detect by three months and held it there at twelve months (90 completers). This evidence measured blood estrone, not saliva, so the effect on salivary estrone has not been directly confirmed.
MedicationStrong Evidence
Increase
Carry excess body fat
More body fat raises estrone, because fat tissue converts other hormones into estrogen. Among 4,068 postmenopausal women, blood estrone averaged roughly 60 percent higher in those with a BMI over 30 than under 25 (30.6 versus 19.1 pg/mL), the largest source of variation in the study. Higher long-term estrogen exposure is linked to hormone-driven breast cancer. Measured in blood, not saliva.
LifestyleStrong Evidence
Decrease
Lose weight through calorie reduction
Fat tissue makes estrogen, so losing weight lowers estrone. In 439 overweight or obese postmenopausal women, a reduced-calorie diet lowered blood estrone by 9.6 percent over 12 months, and diet combined with exercise lowered it by 11.1 percent, with larger drops in women who lost more weight. These results were measured in blood, not saliva.
DietModerate Evidence
Decrease
Exercise regularly without weight loss
Exercise on its own moves estrone only weakly and inconsistently. One trial arm showed a 5.5 percent drop in blood estrone, but a separate year-long aerobic exercise trial in 320 previously sedentary women found no significant change. The reduction appears to track fat loss rather than exercise volume itself. Measured in blood, not saliva.
ExerciseModest Evidence

Frequently Asked Questions

References

19 studies
  1. M. Marder, U. Joshi, I. MandelJournal of Dental Research1979
  2. Rabab Sharif, Sashia Bak-nielsen, H. Sejersen, Kai Ding, J. Hjortdal, D. KaramichosExperimental Eye Research2018
  3. Tina B Mckay, J. Hjortdal, H. Sejersen, J. Asara, Jennifer Wu, D. KaramichosScientific Reports2016
  4. Silvia Alonso, S. Cáceres, Daniel Vélez, L. Sanz, G. Silván, M. Illera, J. IlleraBMC Pregnancy and Childbirth2021
  5. Silvia Alonso, S. Cáceres, Daniel Vélez, L. Sanz, G. Silván, M. Illera, J. IlleraScientific Reports2021